China Merchants Bank Co
-
Shanghai Henlius Biotech has joined a growing pipeline of biotechnology firms planning to float in Hong Kong. It wants to list in the first quarter of 2019, said a banker working on the transaction.
-
Shanghai Junshi Biosciences has raised HK$3.08bn ($394.2m) after pricing its IPO at the bottom of the range, according to a banker on the deal.
-
Bank of Jinzhou is planning to raise HK$8.22bn ($1.05bn) through a private placement of H-shares, according to a filing with the Hong Kong Stock Exchange.
-
Chinese telecommunication software provider AsiaInfo Technologies raised HK$900m ($115m) this week after pricing its flotation at the bottom of the indicative range.
-
Like many recent IPOs in Hong Kong, Chinese telecommunication software provider AsiaInfo Technologies has also priced its listing at the bottom of the indicative range, raising HK$900m ($115m).
-
Fosun Tourism Group, a subsidiary of Chinese conglomerate Fosun International, has raked in HK$3.34bn after sealing its IPO at the bottom of the indicative range.
-
After its successful debut in the Chinese ABS market, Genius Auto Finance, the joint venture between Geely Automobile Holdings and BNP Paribas Personal Finance, scored an equally popular follow-up deal at an even tighter price.
-
WuXi AppTec is set to raise about HK$7.9bn ($1.1bn) from pricing its Hong Kong listing at the mid-point of the indicative price range, according to a source close to the deal.
-
The US and Hong Kong IPO markets saw a raft of companies trying to catch the last window for their listings before the year end, as the short-lived rally from the US-China trade war ceasefire did little to reassure ECM bankers and investors, writes Christie Ou.
-
Australian coal producer Yancoal has raised HK$1.61bn ($206m) from its Hong Kong IPO after pricing it at the bottom of guidance.
-
Fosun Tourism Group, a subsidiary of Chinese conglomerate Fosun International, is being spun-off and has started bookbuilding for its HK$4.28bn ($547.19m) Hong Kong IPO.
-
Shanghai Junshi Biosciences kicked off pre-deal investor education for its Hong Kong listing this week, following close behind Chinese telecommunications software provider AsiaInfo Technologies.